SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-013333
Filing Date
2022-05-09
Accepted
2022-05-09 16:22:01
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20220331.htm   iXBRL 10-Q 809931
2 EX-10.1 ex101leaseamd.htm EX-10.1 24506
3 EX-31.1 fhtx-20220331xex311.htm EX-31.1 9825
4 EX-31.2 fhtx-20220331xex312.htm EX-31.2 9804
5 EX-32.1 fhtx-20220331xex321.htm EX-32.1 4390
6 EX-32.2 fhtx-20220331xex322.htm EX-32.2 4375
  Complete submission text file 0001628280-22-013333.txt   3926357

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20220331.xsd EX-101.SCH 29326
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20220331_cal.xml EX-101.CAL 46482
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20220331_def.xml EX-101.DEF 112176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20220331_lab.xml EX-101.LAB 367896
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20220331_pre.xml EX-101.PRE 222411
48 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20220331_htm.xml XML 572726
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 22905360
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences